Syngene International: Mixed Numbers; Remdesivir Impacts Margins
With elite client additions like Amgen, Zoetis, Herbalife, GSK, etc, and multiple year extension of BMS, Baxter contracts, the company remains well...
416 Views
Yidu Tech IPO Valuation: Attractive at the Low-End but Superior Growth Profile Justifies the Premium
The big data and AI solutions provider for healthcare sector in China, Yidu Tech has set the terms for its IPO and in this insight, we examine Yidu...
732 Views